Search

everythinglearnresearchcommunity

for

Search:↓

Gellan gum hydrogels help recreate the environment needed for hair growth cell function.

Personalized treatments for hair loss are becoming more effective by using genetic information.

The study aims to create a model to predict health attributes using diverse health data from Japanese adults.

The hair growth serum Trichosera® was effective in increasing hair regrowth and density and reducing hair fall without significant side effects.

COVID-19 may worsen hair loss, and Nourkrin® could be a safe treatment option, but more research is needed.

Frontal fibrosing alopecia mainly affects women over 50, causing hair loss and specific skin changes.

This type of hair loss is probably often missed and treatments reducing inflammation might work well.

Extracellular vesicles may effectively treat hair loss with minimal side effects.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

Bimatoprost was found to be safer and more effective than mometasone furoate for treating scalp hair loss.

Intralesional triamcinolone acetonide is more effective than platelet-rich plasma for treating scalp alopecia areata.

Both concentrations of triamcinolone acetonide are effective for hair regrowth in patchy alopecia areata, but 5 mg/mL is recommended to reduce side effects.

Start with 2.5 mg/mL triamcinolone acetonide for scalp alopecia areata and increase if needed.

Intralesional triamcinolone acetonide is better than PRP for treating scalp alopecia areata, leading to faster and more complete hair regrowth.

Combining microdermabrasion with steroid injections improves hair regrowth in scalp alopecia areata.

Azelaic acid 20% cream works well for treating scalp alopecia areata and can be an alternative to clobetasol ointment.

Bimatoprost and clobetasol are both effective for scalp hair loss, but bimatoprost works faster, has fewer side effects, and grows more colored hair.

The combination therapy of microdermabrasion and steroid injections is more effective for treating scalp Alopecia Areata than steroid injections alone.

A 9-year-old girl with alopecia areata had successful hair regrowth using bimatoprost after other treatments failed.

Latanoprost 0.005% solution safely increases hair density and regrowth in scalp alopecia areata.

Reducing the dose of Baricitinib to 2mg still helped over half of the patients with severe scalp alopecia maintain their hair regrowth after two years.

Reducing the dose of Baricitinib to 2mg led to a loss of hair regrowth benefits in nearly half of the patients by Week-104.

Minoxidil is more effective than Latanoprost for treating patchy alopecia areata.

Almost half of the men with beard hair loss also developed scalp hair loss within a year.

Upadacitinib cleared scalp alopecia areata in three patients and also improved atopic dermatitis with minimal side effects.

Trichoscopy is good for diagnosing and monitoring hair and scalp problems in children but needs more research for certain conditions.

Bimatoprost is promising for treating some types of hair loss but needs more testing for androgenetic alopecia.

Alopecia areata is an autoimmune hair loss condition treated with corticosteroids, and histologic confirmation is the best diagnosis method.

Oral tofacitinib is a promising treatment for beard hair loss in alopecia areata.

The study suggests that mast cells might be involved in the hair loss condition telogen effluvium and could be a target for treatment.